A summary of STAT's health policy news coverage and subscription-based access, highlighting vaccine skepticism and Medicare's 60th anniversary within U.S. healthcare context.

Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.

Truist lowers Centene price target to $35 from $42 following Q2 results, citing ongoing cost trend challenges but strong Prescription Drug Plan and Medicare Advantage performance. Buy rating maintained.

Explore key tax law changes in the One Big Beautiful Bill (BBB) affecting individual and corporate taxes, deductions, and credits in the U.S.

The new reconciliation bill increases the federal deficit, reduces health and nutrition support, raises utility costs, and affects clean energy jobs, impacting the U.S. middle class and economy.

HCA Healthcare's Q2 2024 earnings demonstrate strategic growth fueled by digital transformation, aging demographics, and expansion into non-acute care. Strong financial metrics and operational discipline highlight market leadership.

Pediatrix Medical Group to report Q2 2025 results with focus on operational performance, regulatory compliance, and revenue cycle management strategies impacting healthcare insurers and providers.

The New Jersey Supreme Court upheld the state's charity care law requiring hospitals to treat indigent patients despite major declines in state funding. Hospitals face financial challenges amid Medicaid cuts and ACA-driven coverage changes.

OhioHealth warns of potential out-of-network status with Anthem after contract expiration on July 31, 2025, highlighting ongoing negotiations and reimbursement disputes impacting patient coverage and provider payments.

Middletown faces scrutiny over unclear public spending and infrastructure planning, while Rhode Island Medicare Advantage plans drop key hospitals from network, impacting patient costs and care continuity.